# Chronic Kidney Disease CKD in Cats: Stage 1-4 Renal Management Guide


## Key Takeaways

-   Feline Chronic Kidney Disease (CKD) is a progressive, irreversible condition with prevalence increasing significantly with age, affecting up to 50% of cats over 10 years old.
-   The IRIS staging system classifies CKD based on serum creatinine and SDMA levels, further refined by proteinuria (UPCR) and systolic blood pressure, guiding stage-specific management.
-   Early detection is paramount; while increased thirst and urination are classic signs, advanced diagnostics like SDMA and smart litter box monitoring offer earlier detection capabilities.
-   Therapeutic renal diets, low in protein, phosphorus, and sodium, are the cornerstone of management, demonstrably slowing disease progression and improving survival, particularly from Stage 1 onwards.
-   Management involves addressing complications such as anemia (with novel HIF-PHIs like molidustat), hyperphosphatemia, metabolic acidosis, and hypertension, alongside supportive care tailored to the disease stage.
-   Emerging diagnostics like renal cortical thickness on ultrasound and urine GPX4 show promise for earlier and more accurate CKD detection and progression monitoring.

---

Chronic kidney disease (CKD) is a progressive, irreversible condition that is among the most frequently diagnosed metabolic disorders in feline medicine, affecting a substantial proportion of adult and geriatric cats [<a href="#ref-1">1</a>]. The prevalence of CKD increases with age, with estimates ranging from 20% to 50% in cats over 10 years of age [<a href="#ref-1">1</a>]. This guide provides a comprehensive, evidence-based overview of CKD in cats, from the underlying pathophysiology and diagnostic approach to the practical, stage-specific management strategies that can slow disease progression and improve quality of life. For [cat](/knowledge/veterinary-medicine/clinical-methods/cat) owners, the most critical takeaway is that early detection and consistent, veterinarian-guided intervention, particularly dietary therapy, can significantly alter the course of the disease [<a href="#ref-2">2</a>]. If your cat has been diagnosed with CKD, or if you suspect it due to increased thirst and urination, this guide will help you understand what to expect and how to navigate each stage of the condition.

## At a Glance: The Four Stages of Feline CKD

The International Renal Interest Society (IRIS) staging system is the global standard for classifying CKD in cats based on fasting serum creatinine and, increasingly, symmetric dimethylarginine (SDMA) levels. Staging is further refined by assessing proteinuria ([urine protein-to-creatinine ratio](/knowledge/diagnostics/clinical-chemistry/urine-protein-to-creatinine-ratio-interpretation-in-renal-disease), UPCR) and systolic blood pressure. This table provides a practical overview of the stages and their primary management goals.

| IRIS Stage | Key Biomarker Criteria (Serum Creatinine) | Primary Management Focus | Key Interventions |
| :--- | :--- | :--- | :--- |
| **Stage 1** | < 1.6 mg/dL (often with other abnormalities) | Early detection & monitoring | Identify and address underlying causes (e.g., dental disease, hypertension). Consider renal diet [<a href="#ref-2">2</a>]. |
| **Stage 2** | 1.6 - 2.8 mg/dL | Slowing progression | Institute therapeutic renal diet [<a href="#ref-2">2</a>]. Monitor for proteinuria and hypertension. Manage phosphorus intake. |
| **Stage 3** | 2.9 - 5.0 mg/dL | Managing complications | Continue renal diet. Address anemia [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>], hyperphosphatemia, metabolic acidosis, and clinical signs (e.g., nausea). |
| **Stage 4** | > 5.0 mg/dL | Intensive supportive care | Manage uremic crisis, severe anemia, and electrolyte imbalances. Consider subcutaneous fluid therapy and appetite stimulants. |

## Understanding the Feline Kidney and CKD

The kidneys are remarkable organs responsible for filtering waste products from the blood, regulating fluid and electrolyte balance, producing hormones like erythropoietin (EPO), and maintaining acid-base homeostasis. In CKD, there is a progressive loss of functional nephrons, the microscopic filtering units of the kidney. As nephrons are lost, the remaining ones undergo structural and functional changes to compensate, but this compensation eventually fails, leading to the accumulation of toxins in the blood (azotemia) and the clinical signs associated with the disease.

Recent research has illuminated the complex metabolic reprogramming that occurs in the failing feline kidney. A multi-omics study revealed profound changes in renal metabolism, including deranged bioenergetics [<a href="#ref-5">5</a>]. In early-stage disease, the renal medulla shows significant changes in gene expression, with nearly 2,000 differentially expressed genes, while the cortex is less affected. However, as the disease progresses to late stages, the number of altered cortical genes increases to over 4,000 [<a href="#ref-5">5</a>]. This research highlights that CKD is not simply a structural disease but a state of metabolic chaos, with impaired fatty acid oxidation, altered glucose and glutamine metabolism, and disrupted oxygen homeostasis [<a href="#ref-5">5</a>].

Furthermore, advanced imaging techniques are providing new insights into the microstructural changes of the diseased kidney. A recent ex vivo study using 7-Tesla magnetic resonance imaging (MRI) demonstrated that a kidney from a cat with IRIS Stage 2 CKD showed a loss of corticomedullary differentiation on T2-weighted images, a finding that correlated with the degree of interstitial fibrosis seen on histopathology [<a href="#ref-6">6</a>]. This suggests that advanced imaging may one day offer a non-invasive way to assess kidney fibrosis and monitor disease progression in living patients [<a href="#ref-6">6</a>].

## Causes and Risk Factors

CKD in cats is considered a multifactorial disease. While the exact initiating cause is often not identified, several risk factors have been recognized.

- **Age:** The most significant risk factor is age, with prevalence increasing markedly in cats over nine years old [<a href="#ref-1">1</a>].
- **Breed and Sex:** Some studies suggest a higher prevalence in purebred cats and a slightly higher frequency in males compared to females [<a href="#ref-1">1</a>].
- **Environment and Lifestyle:** Indoor-only cats and those fed nutritionally deficient diets have been reported to have a higher prevalence of the disease [<a href="#ref-1">1</a>]. Neutered cats may also be at increased risk [<a href="#ref-1">1</a>].
- **Genetics and Toxins:** Genetic predisposition and exposure to certain toxins can accelerate the progression of renal lesions [<a href="#ref-1">1</a>].
- **Concurrent Disease:** Other conditions, such as chronic dental disease or hypertension, can contribute to the development or progression of CKD [<a href="#ref-1">1</a>].

## Clinical Signs and the Importance of Early Detection

One of the challenges of feline CKD is that clinical signs are often nonspecific and may not appear until significant kidney function has been lost, leading to late diagnosis [<a href="#ref-1">1</a>]. In its early stages, the disease can be silent. When signs do appear, they may include:

- Increased thirst (polydipsia) and increased urination (polyuria)
- Weight loss and decreased appetite
- Lethargy and reduced activity
- Poor coat quality
- Vomiting and diarrhea (or diarrhoea)
- Bad breath (halitosis) with oral ulcers

Early detection is crucial for slowing disease progression. Traditional monitoring relies on blood tests for creatinine and urine tests for urine specific gravity (USG). However, newer biomarkers and technologies are improving our ability to detect CKD earlier.

For example, a study on a smart litter box monitor found that cats with CKD exhibited a unique behavioral profile characterized by increased urination frequency, longer elimination durations, and reduced post-elimination covering behavior [<a href="#ref-7">7</a>]. This technology achieved high predictive accuracy for CKD, suggesting it could provide valuable, continuous, and non-invasive data for early detection and management by cat caregivers [<a href="#ref-7">7</a>].

## Veterinary Examination and Diagnostics

If you suspect your cat has CKD, a thorough veterinary examination is essential. The diagnostic process typically involves:

1.  **Physical Examination:** The veterinarian will assess your cat's body condition, hydration status, and palpate the kidneys, which may feel small and irregular in CKD.
2.  **Blood Tests:** A complete blood count (CBC) and serum biochemistry profile are fundamental.
    - **Serum Creatinine (Cr) and Symmetric Dimethylarginine (SDMA):** These are key biomarkers for assessing kidney function. SDMA is often considered a more sensitive indicator of early disease than creatinine.
    - **Blood Urea Nitrogen (BUN):** Elevated BUN can indicate decreased kidney function, though it can also be affected by diet and hydration.
    - **Electrolytes:** Imbalances in phosphorus, potassium, and calcium are common in CKD.
    - **Hematocrit (HCT)/Packed Cell Volume (PCV):** To check for anemia, a common complication of CKD [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].
3.  **Urinalysis:** This is critical for evaluating the kidney's ability to concentrate urine. A diagnosis of CKD requires a urine specific gravity (USG) of less than 1.035 in the face of azotemia. The urine is also examined for protein and signs of infection. The urine protein-to-creatinine ratio (UPCR) is used to quantify proteinuria, a significant prognostic indicator.
4.  **Blood Pressure Measurement:** Hypertension is a common complication and consequence of feline CKD. Accurate blood pressure assessment is essential for staging and management.
5.  **Diagnostic Imaging:** Abdominal ultrasound is a valuable tool for assessing kidney size, shape, and internal architecture. Recent research has focused on improving the diagnostic accuracy of ultrasonography. A 2026 study found that ultrasonographic parameters, particularly renal cortical thickness (RCT) and its ratios (RCT/Ao, RCT/MT, RCT/RL), were significantly lower in cats with CKD and showed strong negative correlations with BUN, creatinine, and SDMA [<a href="#ref-8">8</a>]. These measurements, especially on the transverse plane, may be superior markers for detecting CKD compared to traditional measurements like renal length [<a href="#ref-8">8</a>].

## Staging and Sub-Staging of CKD

Once a diagnosis of CKD is confirmed, the disease is staged according to the IRIS guidelines. Staging is primarily based on fasting serum creatinine (or SDMA) levels, measured on at least two occasions when the patient is stable. Sub-staging is then performed based on the presence of proteinuria (UPCR) and hypertension.

- **Stage 1:** Creatinine < 1.6 mg/dL. The cat may have other clinical or diagnostic abnormalities, such as inadequate urine concentrating ability or a palpable kidney abnormality.
- **Stage 2:** Creatinine 1.6 - 2.8 mg/dL. This stage is often where clinical signs begin to appear. The cat may have mild azotemia and clinical signs related to kidney dysfunction. Early intervention with a renal diet is particularly beneficial at this stage [<a href="#ref-2">2</a>].
- **Stage 3:** Creatinine 2.9 - 5.0 mg/dL. This is considered moderately to severely azotemic. More pronounced clinical signs are expected, and management of complications like anemia and hyperphosphatemia becomes critical.
- **Stage 4:** Creatinine > 5.0 mg/dL. This is the most advanced stage, characterized by severe azotemia and a high risk of uremic crisis. Intensive supportive care is required.

## Evidence-Based Management of CKD by Stage

Management of feline CKD is a lifelong commitment that focuses on slowing disease progression, managing clinical signs, and maintaining a good quality of life. The approach is tailored to the IRIS stage.

#### Stage 1 Management: Early Detection and Monitoring

The goal in Stage 1 is to identify and address any underlying or contributing factors and to monitor the patient closely.

- **Identify Underlying Causes:** This may include treating chronic dental disease, managing hypertension, or addressing any other concurrent illnesses.
- **Nutritional Intervention:** A landmark retrospective study of 1,430 cats with early CKD found that continuous treatment with a veterinary therapeutic renal diet was associated with a significant reduction in the risk of disease progression [<a href="#ref-2">2</a>]. For Stage 1 cats, dietary therapy was associated with a 45% lower hazard of progression (HR, 0.55; 95% CI, 0.52 to 0.58) [<a href="#ref-2">2</a>]. This suggests that early dietary intervention, even in Stage 1, can be highly beneficial.
- **Monitoring:** Regular blood pressure checks, urine analysis for protein, and blood tests (creatinine/SDMA) are recommended every 3-6 months.

#### Stage 2 Management: Slowing Progression

Stage 2 is a critical window for intervention. The primary goal is to slow the rate of kidney function loss.

- **Therapeutic Renal Diet:** This is the cornerstone of Stage 2 management. The same study showed that Stage 2 cats treated with a renal diet had a 46% (HR, 0.54; 95% CI, 0.50 to 0.58) and 41% (HR, 0.59; 95% CI, 0.56 to 0.62) lower hazard of progression for those with creatinine within and above the reference intervals, respectively [<a href="#ref-2">2</a>]. Treated cats also had a longer survival over 3 years, with a restricted mean survival time of 31.0 months versus 26.0 months in untreated cats [<a href="#ref-2">2</a>]. These diets are designed to be low in protein, phosphorus, and sodium, and are enriched with omega-3 fatty acids and other nutrients to support kidney health.
- **Phosphorus Management:** Restricting dietary phosphorus is important to slow the progression of CKD and manage secondary hyperparathyroidism. If dietary restriction alone is insufficient, a phosphate binder may be recommended. A caregiver survey in Portugal found that of 123 caregivers using a phosphate binder, at least 46 (37.4%) were giving it without food, which is incorrect and reduces its efficacy [<a href="#ref-9">9</a>].
- **Addressing Proteinuria:** If proteinuria is present (UPCR > 0.4), an angiotensin-converting enzyme (ACE) inhibitor may be prescribed to reduce protein loss in the urine.
- **Managing Hypertension:** If hypertension is diagnosed (systolic blood pressure > 160 mmHg), antihypertensive medication is indicated.
- **Calcium and Phosphorus Balance:** The dietary ratio of calcium to phosphorus (Ca:P) is an area of active research. A 2026 study in early-stage CKD cats found that while a higher Ca:P ratio diet (1.8:1) led to a trend for increased serum ionized calcium and fibroblast growth factor 23 (FGF23) compared to a moderate ratio diet (1.4:1), these values remained within the normal reference intervals [<a href="#ref-10">10</a>]. This suggests that while the Ca:P ratio is important, the clinical significance of these differences requires further investigation [<a href="#ref-10">10</a>].

#### Stage 3 Management: Managing Complications

In Stage 3, the focus shifts to actively managing the complications of advancing kidney failure.

- **Continued Dietary and Medical Therapy:** The renal diet remains the foundation. Phosphate binders and antihypertensive medications are often necessary.
- **Managing Anemia:** Anemia is a frequent complication of CKD, primarily due to decreased erythropoietin (EPO) production from the failing kidneys [<a href="#ref-4">4</a>]. Anemia contributes to lethargy and a reduced quality of life [<a href="#ref-4">4</a>]. A novel class of drugs, hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), has shown promise. Molidustat is an oral HIF-PHI that stimulates endogenous erythropoietin synthesis [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. In a multicenter, randomized, double-masked, placebo-controlled field study, 68% of cats treated with molidustat achieved treatment success (a ≥4% point increase in hematocrit) by day 28, compared to only 17% in the control group [<a href="#ref-3">3</a>]. This drug offers a new therapeutic option for managing anemia in cats with CKD [<a href="#ref-4">4</a>].
- **Addressing Metabolic Acidosis:** The kidneys play a vital role in acid-base balance. As CKD progresses, metabolic acidosis can develop, contributing to muscle wasting and a poor appetite. Dietary modification and, in some cases, alkali supplementation may be needed.
- **Gastrointestinal Support:** Nausea, vomiting, and inappetence are common. Anti-emetics and appetite stimulants are often prescribed.
- **Antioxidant Supplementation:** Oxidative stress is a significant contributor to CKD progression. A double-blind, placebo-controlled trial investigated the effect of N-acetylcysteine (NAC) in cats with acute exacerbations of CKD. The study found that NAC (70 mg/kg IV for 7 days) significantly reduced serum creatinine, BUN, and SDMA compared to fluid therapy alone [<a href="#ref-11">11</a>]. Another study evaluated curcumin, a compound with antioxidant and anti-inflammatory properties, in cats with IRIS Stage 3 CKD. Cats receiving 80 mg/cat/day of curcumin for 60 days had significantly lower serum SDMA concentrations and urine protein-to-creatinine ratios compared to the control group, along with improved antioxidant status [<a href="#ref-12">12</a>]. These findings suggest that antioxidant therapies may have a renoprotective role, though they should be used in conjunction with, not as a replacement for, standard medical treatment [<a href="#ref-12">12</a>][<a href="#ref-11">11</a>].
- **Monitoring Calcium and Phosphorus:** Hyperphosphatemia and disturbances in calcium metabolism are common. FGF23 and α-Klotho are key regulators in CKD-mineral and bone disorder (CKD-MBD) [<a href="#ref-13">13</a>]. Urinary FGF23-to-creatinine ratio is significantly elevated in late-stage CKD and acute decompensated CKD compared to early-stage disease [<a href="#ref-13">13</a>]. Monitoring these markers may help guide therapy.

#### Stage 4 Management: Intensive Supportive Care

Stage 4 is the most advanced stage of CKD, and the focus is on intensive supportive care to manage severe clinical signs and maintain comfort.

- **Uremic Crisis Management:** This is a medical emergency. It often requires hospitalization for aggressive intravenous fluid therapy to correct dehydration and flush out toxins. N-acetylcysteine may be a beneficial adjunct to fluid therapy in these cases [<a href="#ref-11">11</a>].
- **Subcutaneous Fluid Therapy:** For long-term management at home, owners are often taught to administer subcutaneous (SC) fluids (e.g., lactated Ringer's solution) to help maintain hydration and reduce azotemia. A caregiver study found that 50.6% of respondents were administering SC fluids at home [<a href="#ref-9">9</a>].
- **Nutritional Support:** Maintaining adequate caloric intake is a major challenge. If the cat is not eating, an esophageal feeding tube may be considered to provide nutrition and medication.
- **Managing Severe Anemia:** In addition to HIF-PHIs like molidustat [<a href="#ref-3">3</a>], blood transfusions may be necessary in cases of severe, life-threatening anemia.
- **Palliative Care:** The goal is to keep the cat comfortable and free from pain. This may involve medications to control nausea, pain, and seizures if they occur.

## The Critical Role of Nutrition and Caregiver Compliance

The success of CKD management hinges on the caregiver's commitment to the treatment plan. A questionnaire-based study in Portugal provided valuable insights into caregiver perspectives and compliance [<a href="#ref-9">9</a>]. While 95.6% of respondents received a recommendation for a renal diet, only 84.2% actually gave it, and of those, 40.8% were ultimately offering at least some non-renal food daily [<a href="#ref-9">9</a>]. This highlights a significant challenge in managing feline CKD. The study also found that while most caregivers felt completely informed by their veterinarian and complied with the recommended monitoring frequency, there are gaps in understanding, such as the correct administration of phosphate binders with food [<a href="#ref-9">9</a>]. Veterinarians and veterinary nurses should prioritize clear communication and ongoing support to help caregivers overcome these barriers.

## Emerging Diagnostics and Monitoring

Beyond traditional blood and urine tests, several new biomarkers are being investigated to improve the diagnosis and monitoring of feline CKD.

- **Ultrasonographic Parameters:** As mentioned, renal cortical thickness and its ratios are emerging as superior markers for detecting CKD [<a href="#ref-8">8</a>].
- **Urine Glutathione Peroxidase 4 (GPX4):** Ferroptosis, a form of iron-dependent cell death, has been implicated in kidney disease. A study found that the urine GPX4-to-creatinine ratio (UGCR) was significantly higher in cats with late-stage CKD and acute-on-chronic kidney disease (ACKD) compared to healthy cats and those with early-stage CKD [<a href="#ref-14">14</a>]. This suggests that UGCR could serve as a progression biomarker [<a href="#ref-14">14</a>].
- **Metanephrines:** A study found that plasma normetanephrine (P-NMN) concentrations were significantly higher in cats with CKD than in healthy cats and correlated with SDMA, creatinine, and UPCR [<a href="#ref-15">15</a>]. This suggests a potential role for the autonomic nervous system in the pathophysiology of feline CKD [<a href="#ref-15">15</a>].
- **Growth Differentiation Factor 8 (GDF8/Myostatin):** While weight loss is common in CKD, a study found that serum GDF8 concentrations were not different between healthy cats and those with early-stage CKD [<a href="#ref-16">16</a>]. However, GDF8 was moderately correlated with muscle condition score, suggesting it may be more related to sarcopenia than to CKD itself [<a href="#ref-16">16</a>].
- **7T MRI:** Advanced imaging like 7T MRI can detect microstructural changes, such as loss of corticomedullary differentiation, that correlate with fibrosis [<a href="#ref-6">6</a>]. While currently a research tool, it may have future clinical applications.

## Unsafe Home Remedies and What to Avoid

It is crucial to avoid any treatments or home remedies that have not been approved by your veterinarian. Some common but dangerous practices include:

- **Over-the-Counter Human Medications:** Never give your cat human medications, especially pain relievers like ibuprofen or acetaminophen, which are highly toxic to cats and can cause acute kidney failure.
- **Unsupervised Supplements:** While some supplements, like curcumin and N-acetylcysteine, have shown promise in clinical trials [<a href="#ref-12">12</a>][<a href="#ref-11">11</a>], they should only be given under veterinary supervision to ensure appropriate dosing and avoid interactions with other medications.
- **Incorrect Fluid Administration:** If your veterinarian has taught you to give subcutaneous fluids, it is vital to use the correct type of fluid, sterile technique, and proper dosage. Giving too much fluid or the wrong type can be harmful.
- **Ignoring Dietary Restrictions:** Offering non-renal food, treats, or table scraps can undermine the benefits of the therapeutic renal diet. The caregiver study showed that a significant number of owners supplement the renal diet with other foods, which can negatively impact disease management [<a href="#ref-9">9</a>].

## Prevention and Long-Term Prognosis

While CKD is not always preventable, regular veterinary check-ups, especially for senior cats, are the best way to detect the disease early. Early detection allows for timely intervention, which can significantly slow progression [<a href="#ref-2">2</a>]. The prognosis for a cat with CKD varies depending on the stage at diagnosis and the response to treatment. Cats diagnosed in early stages and managed appropriately can live for several years with a good quality of life. The use of a therapeutic renal diet has been shown to improve survival [<a href="#ref-2">2</a>].

## Limitations and When to Contact a Veterinarian

This guide provides a comprehensive overview of feline CKD, but it cannot replace professional veterinary advice. The information presented is based on current scientific literature and clinical guidelines, but every cat is an individual, and their response to treatment can vary. Breed-level information cannot predict the exact course of the disease for your specific cat. The genetic and environmental factors that contribute to CKD are complex and not fully understood for every breed [<a href="#ref-1">1</a>].

**You should contact your veterinarian immediately if your cat exhibits any of the following emergency red flags:**

- **Inability to urinate:** This is a life-threatening emergency.
- **Severe lethargy or collapse.**
- **Persistent vomiting or diarrhea (or diarrhoea), especially if the cat cannot keep water down.**
- **Seizures.**
- **Sudden blindness.**
- **A significant drop in appetite or refusal to eat for more than 24 hours.**
- **Difficulty breathing.**

## Frequently Asked Questions

**1. What are the first signs of kidney disease in cats?**
The earliest signs of kidney disease in cats are often subtle and include increased thirst (polydipsia) and increased urination (polyuria), which may manifest as larger urine clumps in the litter box, along with a gradual loss of appetite and weight loss [<a href="#ref-1">1</a>].

**2. How is chronic kidney disease (CKD) staged in cats?**
CKD is staged by a veterinarian using the International Renal Interest Society (IRIS) guidelines, which primarily use fasting blood levels of creatinine and symmetric dimethylarginine (SDMA) to classify the disease into four stages (1 through 4), with sub-staging for proteinuria and hypertension.

**3. Can a cat live a good life with stage 2 kidney disease?**
Yes, many cats with stage 2 kidney disease can live a good quality of life for several years, especially if they are fed a veterinary therapeutic renal diet, which has been shown to slow disease progression and improve survival [<a href="#ref-2">2</a>].

**4. What exactly does a renal diet do for a cat with CKD?**
A veterinary therapeutic renal diet is formulated to be lower in protein, phosphorus, and sodium. This helps to reduce the workload on the kidneys, decrease the buildup of toxins in the blood, and slow the progression of the disease [<a href="#ref-2">2</a>].

**5. Is it safe to give my CKD cat any supplements?**
No, you should never give your cat supplements without veterinary approval. While some, like curcumin and N-acetylcysteine, have shown promise in clinical trials, they must be used under veterinary supervision to ensure correct dosing and safety [<a href="#ref-12">12</a>][<a href="#ref-11">11</a>].

**6. What is the new treatment for anemia in cats with kidney disease?**
A new class of oral drugs called hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), such as molidustat, is now available to treat anemia in cats with CKD by stimulating the body's own production of erythropoietin [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].

**7. How often should my cat with CKD be checked by the vet?**
The frequency of veterinary check-ups depends on the stage of the disease. Generally, more frequent monitoring (every 3-6 months) is recommended for early stages, while cats in later stages may need to be seen more often, sometimes monthly or even more frequently, to manage complications [<a href="#ref-9">9</a>].

**8. What is the life expectancy of a cat with stage 3 kidney disease?**
The life expectancy for a cat with stage 3 CKD varies, but with appropriate management including diet, medication, and supportive care, many cats can maintain a good quality of life for a period of months to a few years. Your veterinarian can give you a more specific prognosis based on your cat's individual response to therapy [<a href="#ref-2">2</a>].

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What are the first signs of kidney disease in cats?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The earliest signs of kidney disease in cats are often subtle and include increased thirst (polydipsia) and increased urination (polyuria), which may manifest as larger urine clumps in the litter box, along with a gradual loss of appetite and weight loss."
      }
    },
    {
      "@type": "Question",
      "name": "How is chronic kidney disease (CKD) staged in cats?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "CKD is staged by a veterinarian using the International Renal Interest Society (IRIS) guidelines, which primarily use fasting blood levels of creatinine and symmetric dimethylarginine (SDMA) to classify the disease into four stages (1 through 4), with sub-staging for proteinuria and hypertension."
      }
    },
    {
      "@type": "Question",
      "name": "Can a cat live a good life with stage 2 kidney disease?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, many cats with stage 2 kidney disease can live a good quality of life for several years, especially if they are fed a veterinary therapeutic renal diet, which has been shown to slow disease progression and improve survival."
      }
    },
    {
      "@type": "Question",
      "name": "What exactly does a renal diet do for a cat with CKD?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A veterinary therapeutic renal diet is formulated to be lower in protein, phosphorus, and sodium. This helps to reduce the workload on the kidneys, decrease the buildup of toxins in the blood, and slow the progression of the disease."
      }
    },
    {
      "@type": "Question",
      "name": "Is it safe to give my CKD cat any supplements?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No, you should never give your cat supplements without veterinary approval. While some, like curcumin and N-acetylcysteine, have shown promise in clinical trials, they must be used under veterinary supervision to ensure correct dosing and safety."
      }
    },
    {
      "@type": "Question",
      "name": "What is the new treatment for anemia in cats with kidney disease?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A new class of oral drugs called hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), such as molidustat, is now available to treat anemia in cats with CKD by stimulating the body's own production of erythropoietin."
      }
    },
    {
      "@type": "Question",
      "name": "How often should my cat with CKD be checked by the vet?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The frequency of veterinary check-ups depends on the stage of the disease. Generally, more frequent monitoring (every 3-6 months) is recommended for early stages, while cats in later stages may need to be seen more often, sometimes monthly or even more frequently, to manage complications."
      }
    },
    {
      "@type": "Question",
      "name": "What is the life expectancy of a cat with stage 3 kidney disease?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The life expectancy for a cat with stage 3 CKD varies, but with appropriate management including diet, medication, and supportive care, many cats can maintain a good quality of life for a period of months to a few years. Your veterinarian can give you a more specific prognosis based on your cat's individual response to therapy."
      }
    }
  ]
}
</script>

## Related Clinical & Scientific Guides

* [Pancreatitis in Dogs: High-Fat Danger, Fluid Therapy and Bland Diets](/knowledge/veterinary-medicine/internal-medicine/pancreatitis-in-dogs-high-fat-danger-fluid-therapy-and-bland-diets)
* [Dilated Cardiomyopathy DCM in Dogs: Diet-Related Taurine Gaps and Recovery](/knowledge/veterinary-medicine/internal-medicine/dilated-cardiomyopathy-dcm-in-dogs-diet-related-taurine-gaps-and-recovery)
* [Addisons Disease in Dogs: Hypoadrenocorticism Crisis Electrolyte Balance](/knowledge/veterinary-medicine/internal-medicine/addisons-disease-in-dogs-hypoadrenocorticism-crisis-electrolyte-balance)